CHAPTER 18 Adrenergic-Blocking Drugs

Slides:



Advertisements
Similar presentations
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 19 Adrenergic-Blocking Drugs.
Advertisements

Antiarrhythmic Agents: Cardiac Stimulants and Depressants
Adrenergic-Blocking Drugs
Pharmacology II The Autonomic Nervous System Adrenergic antagonists
Adrenergic & Adrenergic-blocking Agents
Alpha-Adrenergic Blockers
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 18 Adrenergic Antagonists.
Adrenergic Blockers Asmah Nasser, M.D..
Joseph De Soto MD, PhD, FAIC. Overview The adrenergic antagonist bind adrenoreceptors either reversibly or irreversibly preventing or reducing activation.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic-Blocking Drugs.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Adrenoceptor Blockers
ADRENERGIC ANTAGONITS
Autonomic Nervous System
Chapter 17 Cardiac Stimulants and Depressants. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved
Adrenergic antagonist sympatholytic
Adrenergic Antagonist (Sympatholytics)
DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM 10/8/2015Winter
Adrenergic Blocking Drugs
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
ANTI-ADRENERGIC DRUGS
HuBio 543 September 27, 2007 Neil M. Nathanson K-536A, HSB
Drugs Affecting Blood Pressure Brenda B. Rowe. Vasopressors Treat shock Treat shock Dopamine (Intropin) – stimulates alpha-1 & beta-1 Dopamine (Intropin)
Chapter 33 Agents Affecting the Autonomic Nervous System.
Adrenergic agemts. Learning Objectives Understand the central and peripheral nervous systems, their functions, and their relationship to drugs. Become.
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
 Cardiovascular Effects  α -receptor antagonist drugs lower peripheral vascular resistance and blood pressure.  These drugs can prevent the pressor.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 46 Vasodilators.
Diuretics and Antihypertensives
- If other drug therapies do not achieve the desired reduction in blood pressure, it is sometimes necessary to use a direct vasodilator. - Most of the.
Adrenergic Antagonists (Sympatholytics)
بسم الله الرحمن الرحيم.
Cardiac Stimulants and Depressants
PHARMACOLOGY OF ANS part 3 General Pharmacology M212
Adrenergic Antagonists
ANS True or False Rationale. If I were admitted with decreased circulation to my toes which are blue and painful, you would give me an alpha blocker.
PHARMACOLOGY OFADRENERGICS
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
Adrenergic Receptor Antagonists These are drugs which antagonize α or β or both α and β adrenergic receptors Adrenergic neurone blocking agents (Sympatholytic)
Adrenergic Agonists and Adrenergic Blockers
1 Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. Chapter 42 CARDIAC GLYCOSIDES, ANTIANGINALS, AND ANTIDYSRHYTHMICS.
Adrenergic Antagonists (Sympatholytics). Basic stages in synaptic transmission.
1 ADRENERGIC ANTAGONITS. 2 ADRENERGIC BLOCKERS ALPHA BLOCKERS Alpha 1 Blockers Nonselective Alpha Blockers Doxazosin Phenoxybenzamine Prazosin Phentolamine.
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonists
Peripheral Nervous System
21 Drugs Used to Treat Cardiovascular Conditions.
Drugs Affecting Autonomic Nervous System 1
Sympatholytic & adrenergic blockers -receptor Antagonists
Drugs Affecting The Autonomic Nervous System
Sympatholytic & adrenergic blockers -receptor Antagonists
Antihypertensive Agents
Sympatholytic & adrenergic blockers -receptor Antagonists
Drugs for Autonomic Nervous System
β – ADRENERGIC BLOCKERS
Alpha-Adrenergic Blocking Drugs: Actions and Uses
Chapter 5 Autonomic Drugs.
Antihypertensive Agents
Characteristics of Adrenergic Drugs (p. 291)
Beta-adrenergic blocking agents
Antianginal Drugs.
Effect of β-adrenergic Blockers on the Arterial Blood Pressure
Adrenergic agonists and antagonists
Sympatholytic & adrenergic blockers -receptor Antagonists
Adrenergic Antagonist
Sympatholytic Drugs Adrenergic neuron blockers Adrenergic receptor
Drugs Affecting Blood Pressure
Chaper 20 Adrenoceptor Antagonists
Presentation transcript:

CHAPTER 18 Adrenergic-Blocking Drugs

Adrenergic Blockers Bind to adrenergic receptors, but inhibit or block stimulation of the sympathetic nervous system (SNS) a (alpha)-blockers and b(beta)-blockers

Adrenergic Blockers (cont’d) Have the opposite effect of adrenergic drugs Also known as: Adrenergic antagonists Sympatholytics a-blockers, b-blockers, or a-b–blockers

Adrenergic Blockers (cont’d) Sympatholytics inhibit—or LYSE—sympathetic stimulation

Adrenergic Blockers (cont’d) Classified by the type of adrenergic receptor they block a1 and a2 receptors b1 and b2 receptors

Drug Effects and Indications Ergot alkaloids (a-blockers) Constrict dilated arterioles in the brain Used to treat vascular headaches (migraines) Stimulate uterine contractions (oxytocics) and induce local vasoconstriction Used to control postpartum bleeding

Drug Effects and Indications (cont’d) a-blockers Cause both arterial and venous dilation, reducing peripheral vascular resistance and BP Used to treat hypertension Effect on receptors on prostate gland and bladder decreased resistance to urinary outflow, thus reducing urinary obstruction and relieving effects of BPH

Drug Effects and Indications (cont’d) a-blockers (cont'd) Used to control and prevent hypertension in patients with pheochromocytoma Phentolamine Quickly reverses the potent vasoconstrictive effects of extravasated vasopressors such as norepinephrine or epinephrine Restores blood flow and prevents tissue necrosis

a-Blockers: Adverse Effects Body System Adverse Effects Cardiovascular Palpitations, orthostatic hypotension, tachycardia, edema, dysrhythmias, chest pain CNS Dizziness, headache, drowsiness, anxiety, depression, vertigo, weakness, numbness, fatigue

a-Blockers: Adverse Effects (cont’d) Body System Adverse Effects Gastrointestinal Nausea, vomiting, diarrhea, constipation, abdominal pain Other Incontinence, nosebleed, tinnitus, dry mouth, pharyngitis, rhinitis

Common a-Blockers ergotamine tartrate (Ergostat) phenoxybenzamine HCl (Dibenzyline) phentolamine (Regitine) prazosin (Minipress) tolazoline (Priscoline)

b-Blockers Block stimulation of b receptors in the SNS Compete with norepinephrine and epinephrine Selective and nonselective b-blockers Nonselective b-blockers block both b1 and b2 receptors

b Receptors b1 receptors Located primarily on the heart b-blockers selective for these receptors are called cardioselective b-blockers

b Receptors (cont’d) b2 receptors Located primarily on smooth muscles of bronchioles and blood vessels

Mechanism of Action Cardioselective (b1) Reduces SNS stimulation of the heart Decreases heart rate Prolongs SA node recovery Slows conduction rate through the AV node Decreases myocardial contractility, thus reducing myocardial oxygen demand

Mechanism of Action (cont’d) Nonselective (b1 and b2) Effects on heart: Same as cardioselective Bronchioles: Constriction, resulting in narrowing of airways and shortness of breath Blood vessels: Vasoconstriction Other effects

Indications Antiangina: Decreases demand for myocardial oxygen Cardioprotective: Inhibits stimulation from circulating catecholamines Class II antidysrhythmics

Indications (cont’d) Antihypertensive Some are used to treat heart failure Treatment of migraine headaches Glaucoma (topical use)

Adverse Effects: b-Blockers Body System Adverse Effects Blood Agranulocytosis, thrombocytopenia Cardiovascular AV block, bradycardia, heart failure, peripheral vascular insufficiency CNS Dizziness, mental depression, lethargy, hallucinations

Adverse Effects: Adrenergic-Blocking Drugs b-blockers Body System Adverse Effects Gastrointestinal Nausea, dry mouth, vomiting, diarrhea, cramps, ischemic colitis Other Impotence, rash, alopecia, bronchospasm

b-Blockers: Examples acebutolol (Sectral) carvedilol (Coreg) labetalol (Trandate) metoprolol (Lopressor) atenolol (Tenormin) esmolol (Brevibloc) sotalol (Betapace) propranolol (Inderal)

Adrenergic-Blocking Drugs: Nursing Implications Assess for allergies and history of COPD, hypotension, cardiac dysrhythmias, bradycardia, heart failure, or other cardiovascular problems Any preexisting condition that might be exacerbated by the use of these drugs might be a contraindication to their use

Adrenergic-Blocking Drugs: Nursing Implications (cont’d) Remember that a-blockers may precipitate hypotension Remember that some b-blockers may precipitate bradycardia, hypotension, heart block, heart failure, and bronchoconstriction

Adrenergic-Blocking Drugs: Nursing Implications (cont’d) Avoid OTC medications because of possible interactions Possible drug interactions may occur with: Antacids (aluminum hydroxide type) Antimuscarinics/anticholinergics Diuretics and cardiovascular drugs Neuromuscular blocking drugs Oral hypoglycemic drugs

Adrenergic-Blocking Drugs: Nursing Implications (cont’d) Encourage patients to take medications as prescribed These medications should never be stopped abruptly Report constipation or the development of any urinary hesitancy or bladder distention

Adrenergic-Blocking Drugs: Nursing Implications (cont’d) Teach patients to change positions slowly to prevent or minimize postural hypotension Avoid caffeine (excessive irritability) Avoid alcohol ingestion and hazardous activities until blood levels become stable Patients should notify their physician if palpitations, dyspnea, nausea, or vomiting occurs

b-Blocking Drugs: Nursing Implications Rebound hypertension or chest pain may occur if this medication is discontinued abruptly Patients should notify their physician if they become ill and unable to take medication Inform patients that they may notice a decrease in their tolerance for exercise; dizziness and fainting may occur with increased activity. Notify the physician if these problems occur

b-Blocking Drugs: Nursing Implications (cont’d) Patients should report the following to their physician: Weight gain of more than 2 pounds in 1 day or 5 lb within 1 week Edema of the feet or ankles Shortness of breath Excessive fatigue or weakness Syncope or dizziness

Adrenergic-Blocking Drugs: Nursing Implications Monitor for adverse effects Monitor for therapeutic effects Decreased chest pain in patients with angina Return to normal BP and P Other specific effects, depending on the use